Suppression of lipopolysaccharide-stimulated cytokine/chemokine production in skin cells by sandalwood oils and purified α-santalol and β-santalol

Phytotherapy Research

Volumn 28, Issue 6, 2014, Pages 925-932

  Sharma, M ^a   Levenson, C ^b   Bell, R H ^a   Anderson, S A ^a   Hudson, J B ^c   Collins, C C ^a,d   Cox, M E ^a,d  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b Santalis Pharmaceuticals   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

antiinflammatory; dermal fibroblasts; neo epidermal keratinocytes; prostaglandin; sandalwood oils

Indexed keywords

ANTIINFLAMMATORY AGENT; ARACHIDONIC ACID DERIVATIVE; BETA SANTALOL; CCL1 CHEMOKINE; CXCL16 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; ESSENTIAL OIL; GRANULOCYTE CHEMOTACTIC PROTEIN 2; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IBUPROFEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; LEUKEMIA INHIBITORY FACTOR RECEPTOR; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4; PLANT MEDICINAL PRODUCT; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; RANTES; SANDALWOOD OIL; SANTALOL; THROMBOXANE B2; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG INHIBITION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PROTEIN MICROARRAY; SANTALUM ALBUM; SANTALUM SPICATUM;

SANTALUM;

ANTIINFLAMMATORY; DERMAL FIBROBLASTS; NEO-EPIDERMAL KERATINOCYTES; PROSTAGLANDIN; SANDALWOOD OILS;

AUSTRALIA; CELLS, CULTURED; CHEMOKINES; CYTOKINES; FIBROBLASTS; HUMANS; KERATINOCYTES; LIPOPOLYSACCHARIDES; OILS, VOLATILE; PLANT OILS; SANTALUM; SESQUITERPENES;

EID: 84902296658     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5080     Document Type: Article

References (16)

1. Boniface K, Bernard FX, Garcia M, Gurney AL, Lecron JC, Morel F,. 2005. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 174: 3695-3702.
2. Burdock GA, Carabin G,. 2008. Safety assessment of sandalwood oil (Santalum album L.). Food Chem Toxicol 46: 421-432.
3. Christenson PA, Secord N, Willis BJ,. 1981. Identification of trans- β -santalol and epi-cis- β -santalol in East Indian sandalwood oil. Phytochemistry 20: 1139-1141.
4. Dawes JM, Calvo M, Perkins JR, et al,. 2011. CXCL5 mediates UVB irradiation-induced pain. Sci Transl Med 3 (90): p. 90ra60.
5. Dieu-Nosjan MC, Massacrier C, Homey B, et al,. 2000. Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med 192: 705-18.
6. Dwivedi C, Valluri HB, Guan XM, Agarwal R,. 2006. Chemopreventive effects of α -santalol on ultraviolet B radiation-induced skin tumor development in SKH-1 hairless mice. Carcinogenesis 27: 1917-1922.
7. Gillitzer R, Wolff K, Tong D, et al,. 1993. MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions. J Invest Dermatol 101: 127-31.
8. Jones CG, Plummer JA, Barbour EL, Byrne M,. 2009. Genetic diversity of an Australian Santalum album collection-implications for tree improvement potential. Silvae Genet 58: 279-286.
9. Magni P, Ruscica M, Dozio E, Rizzi E, Beretta G, Maffei Facino R,. 2012. Parthenolide inhibits the LPS-induced secretion of IL-6 and TNF-α and NF-κB nuclear translocation in BV-2 microglia. Phytother Res 26 (9): 1405-9.
10. Moy RL, Levenson C, So JJ, Rock J,. 2012. Single-center, open-label study of a proprietary topical 0.5% salicylic acid-based treatment regimen containing sandalwood oil in adolescents and adult with mild to moderate acne. J Drugs Dermatol 11: 1403-1408.
11. Nickoloff BJ, Turka LA,. 1994. Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immuno Today 15: 464-9.
12. Paulpandi M, Kannan S, Thangam R, Kaveri K, Gunasekaran P, Rejeeth C,. 2012. Phytomedicine 19 (3-4): 231-5.
13. Rao P, Knaus EE,. 2008. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J Pharm Pharm Sci 11 (2): 81s-110s.
14. So PL, Tang JY, Epstein EH,. 2010. Novel investigational drugs for basal cell carcinoma. Expert Opin Invest Drugs 19: 1099-1112.
15. Walz A, Schmutz P, Mueller C, Schnyder-Candrian S,. 1997. Regulation and function of the CXC chemokine ENA-78 in monocytes and its role in disease. J Leukoc Biol 62: 604-611.
16. Yan YY, Wang YW, Chen SL, Zhuang SR, Wang CK,. 2013. Anti-inflammatory effects of phenolic crude extracts from five fractions of Corchorus olitorius L. Food Chem 138 (2-3): 1008-14.